최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품과학회지 = Korean journal of food science and technology, v.40 no.6 = no.202, 2008년, pp.674 - 679
신정민 (서울대학교 식품영양학과 생활과학연구소) , 박찬경 (서울대학교 식품영양학과 생활과학연구소) , 신은주 ((주)유니베라) , 조태형 ((주)남양에코넷기업본부) , 황인경 (서울대학교 식품영양학과 생활과학연구소)
Scutellaria radix (SR) has been utilized as a traditional medicine for a variety of diseases including Rheumatoid arthritis and its major flavonoids - baicalein, baicalin, and wogonin - have been reported to exert beneficial health effects, including anti-bacterial, anti-viral, anti-inflammatory, an...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
황금 추출물의 세포에 독성을 나타내지 않은 범위에서 조골세포 표지 효소인 alkaline phosphatase 활성을 측정한 결과는? | 황금 추출물이 세포에 독성을 나타내지 않는 범위(0.01-1 µg/mL)에서 ALP activity를 측정한 결과, 황금 추출물은 농도 의존적이고 유의적으로 ALP activity가 증가하였으며 1 µg/mL 농도에서 152.0%의 ALP 활성 증가효과를 나타내었다. ALP는 조골 세포의 분화에 발현되는 표식인자(biomarker)이므로 이 결과에 의해 황금 추출물이 조골세포의 분화를 촉진하는 가능성이 있음을 유추할 수 있다. | |
뼈의 재형성에 관여하는 두 종류 세포는 어떤 역할을 하는가? | 이러한 뼈의 재형성(bone remodeling)에는 두 종류의 특수한 기능을 하는 세포가 관여한다. 파골세포는 뼈를 흡수하는 반면, 조골세포는 뼈기질을 합성하고 채우는 역할을 한다. 따라서 골량은 이러한 세포의 상대적인 기능에 의존하게 된다. | |
황금에 함유된 페놀 화합물 중 가장 많이 함유된 물질은? | 뿌리에는 35% 이상의 페놀화합물을 포함하며 노란색을 띄기 때문에 황금(黃芩: golden root)이라 한다. 황금은 baicalin, baicalein, wogonin이 많이 함유되어 있으며, 그 중 baicalin이 가장 많이 함유되어 있다. 오래전부터 우리나라, 중국, 일본 등에서 황금을 항산화 효과와 함께 소염성 해열, 진통, 지사, 염증성 결막염, 두통, 위염, 장염 등에 사용되어 왔으며 최근에는 고혈압, 동맥경화, 피부질환, 불면, 감기, 상습유산에도 사용되고 있다(16). |
Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J. Clin. Invest. 81:277-281 (1988)
Raisz LG. Hormonal regulation of bone growth and remodeling. In Cell and Molecular Biology of Vertebrate Hard Tissue CIBA Foundation Symposium 136, pp. 226-238, Wiley, NY, USA (1988)
Lee YS. Effect of isoflavones on proliferation and oxidative stress of MC3T3-E1 osteoblast-like cells. Korea soybean Digest. 18: 35-42 (2001)
Jilka RL. Cytokines, bone remodeling and estrogen deficiency. Bone 23: 75-81 (1998)
Aldercreutz H, Mazur W. Phyto-estrogens in relation to cancer and other human health risks. Proc. Nutr. Soc. 55: 399-417 (1996)
Keum JC, Kang KH, Kim SB. Effects of estrogen on the tumor necrosis factor- ${\alpha}$ induced apoptosis and cytokine gene expression MC3T3-E1 osteoblast. Korean J. Obstet. Gynecol. 44: 324-336 (2001)
Orcel P, Krane SM. Secondary osteoporosis and glucocorticoid include osteoporosis. Ann. Med. Interne. 151: 497-502 (2000)
Karen MP, Carol CP, Lawrence GR. Treatment of osteoporosis. Annu. Rev. Med. 6: 249-256 (1995)
Stein GS, Lian JB, van Wijnen AJ, Montechino M. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76: 593-629 (1996)
Ryan PJ, Evans P, Gibson T, Fogelman I. Osteoporosis and chronic back pain: A study with single-photon emission computed tomography bone scintigraphy. J. Bone Miner. Res. 7: 1455-1460 (1992)
Cho SH, Kim KG, Kim SR, Lee JA, Moon H, Hwang YY. The effects of 17- ${\beta}$ estradiol, medroxyprogesterone acetate and parathyroid hormone on the differentiation of osteoblast cell. Korean J. Obstet. Gynecol. 39: 1497-1506 (1996)
Boonen A, Broos P, Deqeker J. The prevention of treatment of age-related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF-I or rhRGF- ${\beta}$ ): a perspective. J. Internal Med. 242: 285-290 (1997)
Lee YS. Effect of isoflavones on proliferation and oxidatives stress of MC3T3-E1 osteoblastic like cells. Korea Soybean Digest. 18: 35-42 (2001)
Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. Soybean ethanol extract increases the funtion of osteoblastic MC3T3-E1 cells. Phytochemistry 56: 733-739 (2001)
Choi EM, Koo SJ. Effects of soybean ethanol extract on the prostaglandin E2 and interleukin-6 production in osteoblastic cells. Food Res. Int. 2002, 35: 893-896 (2002)
Herbal medicine. Young-lim Sa. Seoul, pp. 218-220 (2004)
Chena YC, Shenb SC, Chena LG, Tony JF, Yang LL. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61: 1417-1427 (2001)
Krakauer T, Li B, Young H. The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS. Lett. 500:52-55 (2001)
Jerome AR, Kim BG. Melatonin Promotes Osteoblast Differentiation and Bone Formation. J. Biol. Chem. 274: 22041-22047 (1999)
Green LM, Reade JL, Ware CF. Rapid colometric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lympokines. J. Immunol. Methods 70: 257 (1984)
Owen ME. Lineage of osteogenic cells and their relationship to the stromal system. in Bone and Mineral Research, edited by Peck, W.A., pp. 1-25, Elsevier Science Publisher, Amsterdam (1985)
Martin JH, Matthews JL. Mitochondrial granules in chondrocytes, osteoblasts and osteocytes. An ultrastructural and microincineration study. Clin. Orthop. Relat. R. 68: 237-278 (1970)
Ernst M, Heath JK, Lodan GA. Estradiol effects on proliferation messenger ribonucleic acid collagen and insulin-like growth factor-I and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125: 822-833 (1989)
Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96: 191-198 (1983)
Kim KY, Lee CS, Lee SH, Lee JD, Kim GS. Primary culture of osteoblast. J. Korean Orthop. Assoc. 26: 1860-1863 (1991)
Cho YH, Park SJ, Shin HJ, Jang KH, Kang SA, Cho RW. Comparative estrogenic effects of Yak-Kong and Soy Bean on the proliferation of human osteoblastic cell line, MG-63. Korean J. Nutr. Soc. 34: 905-911 (2001)
Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation for tissue-specific gene expression during osteoblast differentiation. FASEB. J. 4: 3111-3123 (1990)
Park SK, Shin HS. Effects of extract of natural products on alkaline phosphatase activity of MC3T3-E1 cells. Wonkwang Dental Medicine 10: 89-100 (2001)
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-57 (1999)
Mundy GR, Roodman GD. Osteoclast ontogeny and function. Vol. 5, pp. 209-279. In: Bone and Mineral Research, Peck WA (ed). Elsevier, Amsterdam, Netherland (1987)
Claudia MR, Michele L, Gilles C, Alain P, Giulia C. Down-Regulation of osteoclast differentiation by Daidzein via Caspase 3. J. Bone Miner. Res. 17: 630-638 (2002)
Alice W, Said K, Romuald M, Florence L, Christophe P, Petit JP, Patrice F, Michel B. Potent inhibitory effect of naturally occurring flavonoids ruercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem. Pharmacol. 65: 35-42 (2003)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.